BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley

Company Overview - BioMarin has undergone significant changes in strategy, structure, pipeline, and portfolio since December 2023 [2] - The company has demonstrated strong execution and progress, particularly noted in the last quarter [2] Financial Performance - BioMarin reported a 16% revenue growth in the last quarter, continuing a trend of strong financial and commercial performance [3]